ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2
Article in Antiviral Research (October 2023)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1
Article in Journal for ImmunoTherapy of Cancer (March 2023)
Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses
Article in iScience (April 2021)